Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Continued progress thru' Microsaic collaboration

23 Aug 2021 07:00

RNS Number : 3911J
Deepverge PLC
23 August 2021
 

 

 

 

DeepVerge plc

("DeepVerge")

 

DeepVerge collaborate with Microsaic Systems plc to launch range of miniature mass spectrometers with triple quadrupole limits of detection for organic chemical analysis in water and soil

 

Combined micro-engineering technology, software and AI create unique identification detection system for Chemicals of Emerging Concern[i] (CEC) and Forever Chemicals[ii] (PFAS)

 

DeepVerge (LSE:DVRG.L), is pleased to announce continued progress through its collaboration with Microsaic Systems plc (AIM: MSYS) to provide real-time monitoring solutions to detect and identify contaminants in water and soil.

 

Microsaic has launched a miniaturised mass spectrometer platform which provides fully integrated front-end solutions, with software upgrades using AI from DeepVerge, to achieve triple quadrupole limits of detection for real-time monitoring and identification of organic chemicals in water and soil. 'Triple quad' limits of detection mean increased sensitivity and specificity, which allows detection and quantitation at lower limits than conventional single quadrupole mass spectroscopy.

 

DeepVerge plc environmental division has implemented real-time services for the automated detection and identification of metals and pathogens[iii] and adding the Microsaic platform augments this offering with automated real time detection and expert analysis of dangerous organic chemicals in water and soil.

 

· Detection capability for a variety of contaminants and toxic bad actors adds:

o Organic chemical expertise and detection of CECs, currently unregulated and unmeasured, with the European Chemical Agency in 2020, identifying 290 chemical candidates for regulatory action by the European Commission[iv];

· New platform augments revenue channels of both companies without re-engineering business infrastructure:

o Screening - project deployment (e.g. Site remediation, clean up, chronic or acute spills), mobile laboratory/van etc.;

o Monitoring - site surveillance (e.g. waste water treatment plants, sites of special interest)

· Retrofit or standalone integration of high-tech hardware, software and AI adds:

o Unified data handling;

o Unified/integrated sampling strategies;

o Unified front to customers installations and collaborations;

o Powerful and accurate analysis of aggregated data with AI delivering the ability to detect an array of targets in a single platform and with predictive alert capability;

 

The new portable Microsaic platform, with triple quadrupole limits of detection is unique, bringing laboratory quality performance to the front-line, at a fraction of the cost and up to 90% smaller than traditional triple quadrupole mass spectrometry equipment, reducing workflows and allowing real-time manual, or automated, decision making in real-time.

 

Gerard Brandon, DeepVerge plc CEO commented:

"By combining our expertise in contaminant monitoring, we are able to offer new, innovative real-time monitoring solutions to our existing customers and open new global opportunities for fully-integrated water and soil detection of a broad range of pathogens and chemicals not least of which is the current COVID-SARS-CoV-2 global health crisis, providing the potential to identify virus hotspots in real-time."

 

Glenn Tracey, CEO of Microsaic Systems plc, commented:

"The Microsaic team has achieved two major milestones: first, a range of miniaturised portable mass spectrometry systems with triple quadrupole limits of detection, and second, access to new sources of income from revenue sharing monitoring services that offer protection to society against the silent killer of chemicals of emerging concern."

 

"The combination of Microsaic and DeepVerge capabilities provides impressive coverage between chemicals and pathogens in our waters and soil. The Microsaic Board believes that data driven monitoring capability is of great interest to government, industrial and agricultural stakeholders which is already seen from significant interest from clients."

 

Enquiries:

 

 

DeepVerge plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

 

 

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

About DeepVerge plc (www.deepverge.com)

 

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

About Microsaic (www.microsaic.com)

 

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

 

Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications. 

 

 

[i] https://www.microsaic.com/news/the_truth_about_the_silent_undetected_killers_in_our_waters/

[ii] https://www.microsaic.com/news/5-enivronmental-issues-real-time-diagnosis-can-help-solve/

[iii] Pathogens (virus, bacteria, toxins and parasites)

[iv] https://echa.europa.eu/-/nearly-300-chemicals-identified-as-candidates-for-regulatory-action

 

About Reach announcements

 

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUUAKRANUWUAR
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.